Clinical Trials Browser

Phase 1 × Infusions, Intravenous × Other hematologic neoplasm × Clear all

NCT05001451 2022-07-20

Study of GDX012 in Patients With MRD Positive AML

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute